PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-0.25%
Revenue decline while CRON.TO shows 114.03% growth. Joel Greenblatt would examine competitive position erosion.
42.84%
Cost increase while CRON.TO reduces costs. John Neff would investigate competitive disadvantage.
-11.81%
Gross profit decline while CRON.TO shows 87.42% growth. Joel Greenblatt would examine competitive position.
-11.59%
Both companies show margin pressure. Martin Whitman would check industry conditions.
10.45%
R&D change of 10.45% while CRON.TO maintains spending. Bruce Berkowitz would investigate effectiveness.
71.57%
G&A growth while CRON.TO reduces overhead. John Neff would investigate operational differences.
3.83%
Marketing expense change of 3.83% while CRON.TO maintains spending. Bruce Berkowitz would investigate effectiveness.
-11.93%
Other expenses reduction while CRON.TO shows 17.13% growth. Joel Greenblatt would examine efficiency.
31.72%
Operating expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
34.31%
Total costs growth while CRON.TO reduces costs. John Neff would investigate differences.
334.21%
Interest expense growth above 1.5x CRON.TO's 113.53%. Michael Burry would check for over-leverage.
12.61%
D&A growth 50-75% of CRON.TO's 17.13%. Bruce Berkowitz would examine asset strategy.
-156.43%
EBITDA decline while CRON.TO shows 113.99% growth. Joel Greenblatt would examine position.
-598.40%
EBITDA margin decline while CRON.TO shows 103.20% growth. Joel Greenblatt would examine position.
-1070.05%
Operating income decline while CRON.TO shows 98.74% growth. Joel Greenblatt would examine position.
-1072.51%
Operating margin decline while CRON.TO shows 99.41% growth. Joel Greenblatt would examine position.
1252.78%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
433.16%
Pre-tax income growth 50-75% of CRON.TO's 605.09%. Martin Whitman would scrutinize operations.
434.51%
Pre-tax margin growth exceeding 1.5x CRON.TO's 229.44%. David Dodd would verify competitive advantages.
-6370.24%
Both companies reducing tax expense. Martin Whitman would check patterns.
433.16%
Similar net income growth to CRON.TO's 560.97%. Walter Schloss would investigate industry trends.
434.51%
Net margin growth exceeding 1.5x CRON.TO's 208.82%. David Dodd would verify competitive advantages.
306.74%
EPS growth below 50% of CRON.TO's 710.00%. Michael Burry would check for structural issues.
306.74%
Diluted EPS growth below 50% of CRON.TO's 912.50%. Michael Burry would check for structural issues.
17.10%
Share count reduction below 50% of CRON.TO's 1.71%. Michael Burry would check for concerns.
16.43%
Diluted share increase while CRON.TO reduces shares. John Neff would investigate differences.